tiprankstipranks
Acurx Pharmaceuticals (ACXP)
NASDAQ:ACXP
Holding ACXP?
Track your performance easily

Acurx Pharmaceuticals (ACXP) Financial Statements

125 Followers

Acurx Pharmaceuticals Financial Overview

Acurx Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.095; its P/E ratio is -1.20; Acurx Pharmaceuticals is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.82M$ -4.12M$ -4.38M$ -5.11M$ -3.11M
EBITDA$ -2.82M$ -4.12M$ -4.38M$ -5.11M$ -3.11M
Net Income Common Stockholders$ -2.82M$ -4.12M$ -4.38M$ -5.11M$ -3.12M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.80M$ 6.40M$ 8.90M$ 7.50M$ 7.10M
Total Assets$ 6.02M$ 6.58M$ 9.11M$ 7.71M$ 7.16M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -5.80M$ -6.40M$ -8.90M$ -7.50M$ -7.10M
Total Liabilities$ 3.32M$ 3.15M$ 3.11M$ 3.04M$ 3.22M
Stockholders Equity$ 2.66M$ 3.43M$ 6.00M$ 4.67M$ 3.93M
Cash Flow-
Free Cash Flow$ -2.19M$ -2.88M$ -3.06M$ -4.20M$ -2.09M
Operating Cash Flow$ -2.19M$ -2.88M$ -3.06M$ -4.20M$ -2.09M
Investing Cash Flow-----
Financing Cash Flow$ 1.59M$ 320.21K$ 4.51M$ 4.62M-
Currency in USD

Acurx Pharmaceuticals Earnings and Revenue History

Acurx Pharmaceuticals Debt to Assets

Acurx Pharmaceuticals Cash Flow

Acurx Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis